Natera, Inc. (NTRA)
326.22
-12.48
(-3.68%)
USD |
NASDAQ |
Aug 28, 16:00
326.00
-0.22
(-0.07%)
After-Hours: 20:00
Natera Cash from Operations (Quarterly) : 54.79M for June 30, 2026
Cash from Operations (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 54.79M |
| March 31, 2026 | 40.17M |
| December 31, 2025 | 73.89M |
| September 30, 2025 | 59.39M |
| June 30, 2025 | 37.57M |
| March 31, 2025 | 44.45M |
| December 31, 2024 | 52.89M |
| September 30, 2024 | 51.79M |
| June 30, 2024 | 3.99M |
| March 31, 2024 | 27.00M |
| December 31, 2023 | -58.12M |
| September 30, 2023 | -29.56M |
| June 30, 2023 | -78.38M |
| March 31, 2023 | -80.89M |
| December 31, 2022 | -81.13M |
| September 30, 2022 | -102.25M |
| June 30, 2022 | -110.85M |
| March 31, 2022 | -137.28M |
| December 31, 2021 | -98.74M |
| September 30, 2021 | -91.06M |
| June 30, 2021 | -70.56M |
| March 31, 2021 | -74.88M |
| December 31, 2020 | -73.30M |
| September 30, 2020 | -33.13M |
| June 30, 2020 | -40.98M |
| Date | Value |
|---|---|
| March 31, 2020 | -35.10M |
| December 31, 2019 | -15.05M |
| September 30, 2019 | -12.64M |
| June 30, 2019 | -3.932M |
| March 31, 2019 | -31.82M |
| December 31, 2018 | -12.81M |
| September 30, 2018 | -23.27M |
| June 30, 2018 | -35.54M |
| March 31, 2018 | 1.046M |
| December 31, 2017 | -28.13M |
| September 30, 2017 | -31.30M |
| June 30, 2017 | -13.77M |
| March 31, 2017 | -24.62M |
| December 31, 2016 | -29.59M |
| September 30, 2016 | -24.30M |
| June 30, 2016 | -20.71M |
| March 31, 2016 | 0.55M |
| December 31, 2015 | -4.719M |
| September 30, 2015 | -17.24M |
| June 30, 2015 | -13.14M |
| March 31, 2015 | -2.457M |
| December 31, 2014 | |
| September 30, 2014 | 5.843M |
| June 30, 2014 | -0.442M |
| March 31, 2014 | -5.039M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| Guardant Health, Inc. | -57.78M |
| CareDx, Inc. | 30.60M |
| Myriad Genetics, Inc. | -8.30M |
| BioRestorative Therapies, Inc. | -3.808M |
| Exagen, Inc. | 3.988M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -63.43M |
| Cash from Financing (Quarterly) | 12.21M |
| Free Cash Flow | 51.20M |
| Free Cash Flow Per Share (Quarterly) | -0.0603 |
| Free Cash Flow to Equity (Quarterly) | -7.043M |
| Free Cash Flow to Firm (Quarterly) | -7.750M |
| Free Cash Flow Yield | 0.11% |